Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored ...

BARDA has given $24 million to Locus Bio to support a mid-stage trial of bacteriophage therapy LBP-EC01 for resistant E coli infections.

Given the past two years’ and ongoing experience with SARS-CoV-2 and its variants, the BARDA multi-year contract - potentially an investment of up to $1 billion in total - aims to continue the ...

Get the latest Vaxart, Inc. (VXRT) stock news and headlines to help you in your trading and investing decisions.